Belgium-based life sciences company Pronota has finally closed its second round of funding after nearly a year with a final total of €7.9m ($9.8m). Johnson and Johnson Development Corporation, the in-house venture capital arm of the US-based consumer and medical goods company, and MP Healthcare Venture Management, a jointly-owned subsidiary of Mitsubishi Tanabe Pharma Corp and its parent Mitsubishi Chemical, had originally backed Pronota’s series B last summer. The additional €1.5m ($1.9m) came from MedSciences Capital, the venture capital arm of Dutch merchant bank Kempen. Pronota’s other investors included Benelux-based private equity firm GIMV, Biotech Fund Flanders, Life Science Partners, KBC Private Equity, VIB and the Baekeland fund, the venture capital fund of the Ghent University Association. In August 2006, Pronota, when it was called Peakadilly, closed its series A financing at €14.5m ($18.2m), two years after the company was founded. Its series A round investors were GIMV, Life Science Partners, KBC Private Equity, Baekeland and Johnson and Johnson Development Corporation.
- News & Analysis
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Deal Data
- Community & Events
Pronota finally closes second funding round
May 27, 2010 • James Mawson
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Featured ContentFUNDING ROUND DATA Which corporates are backing which startups? Search our corporate deal database.
FUNDING ROUND DATA
Which corporates are backing which startups? Search our corporate deal database.NOMINATE Nominations for the GCV Powerlist 2024 are now open
Nominations for the GCV Powerlist 2024 are now openEventsWebinar: Startups and Strategics – What works and what doesn’tEventsGCV Institute: Landing the Value of Corporate VenturingTop News
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.test reg